Skip to main content
رجوع
ONC logo

BeOne Medicines Ltd.

جودة البيانات: 100%
ONC
NASDAQ Healthcare Medical - Pharmaceuticals
KWD 283.45
▲ KWD 7.76 (2.81%)
القيمة السوقية: 30.29B
نطاق اليوم
KWD 279.96 KWD 285.53
نطاق 52 أسبوعًا
KWD 196.45 KWD 385.22
حجم التداول
159,515
متوسط 50 يوم / 200 يوم
KWD 329.69 / KWD 314.04
الإغلاق السابق
KWD 275.69

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 105.6 0.2
P/B 7.0 3.0
ROE % 7.5 3.6
Net Margin % 5.4 3.8
Rev Growth 5Y % 46.0 9.7
D/E 0.5 0.2

السعر المستهدف للمحللين

Hold
KWD 409.67 +44.5%
Low: KWD 394.00 High: KWD 425.00
مكرر الربحية المستقبلي
46.60
ربحية السهم المستقبلية
KWD 6.08
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
6.40B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 19.49
KWD 18.53 – KWD 20.81
 10.41B 4
FY2029 KWD 16.17
KWD 15.38 – KWD 17.26
 9.27B 4
FY2028 KWD 12.93
KWD 8.18 – KWD 18.18
 8.34B 10

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 KWD 1.24 KWD 0.58 -53.2%
2025-11-06 KWD 0.72 KWD 1.09 +51.4%
2025-08-06 KWD 0.48 KWD 0.84 +75.0%
2025-05-07 -KWD 0.71 KWD 1.22 +271.8%
2025-02-27 -KWD 0.88 -KWD 1.43 -62.5%
2024-11-12 -KWD 0.88 -KWD 1.15 -30.7%
2024-08-07 -KWD 2.10 -KWD 1.15 +45.2%
2024-03-31 N/A -KWD 2.41 —

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 45.99% annually over 5 years — strong growth
Debt/Equity of 0.46 — conservative balance sheet
Generating 941.74M in free cash flow
P/E of 105.56 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.76%
Cash machine — converts 328.21% of earnings into free cash flow

النمو

Revenue Growth (5Y)
45.99%
Revenue (1Y)40.23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
7.46%
ROIC5.27%
Net Margin5.37%
Op. Margin8.37%

الأمان

Debt / Equity
0.46
Current Ratio3.41
Interest Coverage7.68

التقييم

P/E Ratio
105.56
Forward P/E46.60
P/B Ratio6.95
EV/EBITDA62.04
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 40.23% Revenue Growth (3Y) 47.41%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 45.99% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5.34B Net Income (TTM) 286.93M
ROE 7.46% ROA 3.50%
Gross Margin 87.49% Operating Margin 8.37%
Net Margin 5.37% Free Cash Flow (TTM) 941.74M
ROIC 5.27% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.46 Current Ratio 3.41
Interest Coverage 7.68
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 105.56 Forward P/E 46.60
P/B Ratio 6.95 P/S Ratio 5.67
PEG Ratio -0.18 Forward PEG N/A
EV/EBITDA 62.04 Fwd EV/EBITDA N/A
Forward P/S 4.73 Fwd Earnings Yield 2.15%
FCF Yield 3.11%
Market Cap 30.29B Enterprise Value 27.74B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.34B 3.81B 2.46B 1.42B 1.18B
Net Income 286.93M -644.79M -881.71M -2.00B -1.46B
EPS (Diluted) 32.89 -6.12 -8.45 -19.37 -15.21
Gross Profit 4.67B 3.22B 2.08B 1.13B 1.01B
Operating Income 447.14M -568.20M -1.21B -1.79B -1.44B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.19B 5.92B 5.81B 6.38B 8.54B
Total Liabilities 3.83B 2.59B 2.27B 2.00B 2.40B
Shareholders' Equity 4.36B 3.33B 3.54B 4.38B 6.13B
Total Debt 2.00B 1.08B 930.19M 596.68M 694.64M
Cash & Equivalents 4.55B 2.63B 3.17B 3.87B 4.38B
Current Assets 6.23B 3.99B 4.20B 5.21B 7.61B
Current Liabilities 1.83B 2.21B 1.81B 1.47B 1.60B

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#397 of 1049
50

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026